USANA Health Ownership
| USNA Stock | USD 39.90 0.54 1.37% |
Shares in Circulation | First Issued 1994-03-31 | Previous Quarter 19.2 M | Current Value 19.1 M | Avarage Shares Outstanding 33.8 M | Quarterly Volatility 10.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
USANA |
USANA Stock Ownership Analysis
About 42.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.41. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. USANA Health Sciences has Price/Earnings To Growth (PEG) ratio of 1.2. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of November 2016. USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people. For more information please call Kevin Guest at 801 954 7100 or visit https://www.usana.com.Besides selling stocks to institutional investors, USANA Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different USANA Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align USANA Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
USANA Health Quarterly Liabilities And Stockholders Equity |
|
USANA Health Insider Trades History
About 42.0% of USANA Health Sciences are currently held by insiders. Unlike USANA Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against USANA Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of USANA Health's insider trades
USANA Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as USANA Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading USANA Health Sciences backward and forwards among themselves. USANA Health's institutional investor refers to the entity that pools money to purchase USANA Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 179 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 137.7 K | Assenagon Asset Management Sa | 2024-09-30 | 124 K | Ubs Group Ag | 2024-06-30 | 123.1 K | Northern Trust Corp | 2024-09-30 | 116.7 K | Bank Of New York Mellon Corp | 2024-06-30 | 97.4 K | Amvescap Plc. | 2024-06-30 | 86.6 K | Jpmorgan Chase & Co | 2024-06-30 | 64.8 K | Goldman Sachs Group Inc | 2024-06-30 | 57.5 K | Blackrock Inc | 2024-06-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.6 M |
USANA Health Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific USANA Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on USANA Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases USANA Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
USANA Health Outstanding Bonds
USANA Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. USANA Health Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USANA bonds can be classified according to their maturity, which is the date when USANA Health Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| UPC HLDG BV Corp BondUS90320LAG23 | View | |
| USAACA 3375 01 MAY 25 Corp BondUS90327QD891 | View | |
| US90327QD552 Corp BondUS90327QD552 | View | |
| US90320WAD56 Corp BondUS90320WAD56 | View | |
| US90320BAA70 Corp BondUS90320BAA70 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
USANA Health Corporate Filings
F4 | 18th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 21st of October 2024 Other Reports | ViewVerify | |
10Q | 6th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.